Marija Gjorgoska | Molecular Diagnostics | Best Researcher Award

Ms. Marija Gjorgoska | Molecular Diagnostics | Best Researcher Award 

Asistant, at Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Slovenia.

Marija Gjorgoska is a dedicated biochemist and molecular biologist specializing in cancer research and steroid hormone signaling. Currently a Teaching and Research Assistant at the Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, she contributes to both education and cutting-edge biomedical research. With a strong foundation in LC-MS/MS and bioinformatics, Marija’s work focuses on cancer tissue analysis and hormone-related pathophysiology. Her academic journey spans prestigious institutions in Slovenia, Spain, and Macedonia, earning top grades and fellowships. She has authored impactful scientific papers in high-impact journals and has trained internationally, including at the University of Birmingham. Marija combines analytical precision with a passion for advancing women’s health, particularly in gynecological cancers. Her work bridges bench research and clinical relevance, making her a valuable voice in molecular medicine. Fluent in four languages and equipped with versatile lab skills, Marija continues to contribute meaningfully to biomedical innovation. 🌍🧪📚

Professional Profile

Scopus

🎓 Education

Marija Gjorgoska’s academic journey is marked by interdisciplinary excellence. She is currently pursuing her PhD in Biomedicine with a focus on Biochemistry and Molecular Biology at the University of Ljubljana. Prior to this, she completed an MSc in Molecular Biology at the same university with a remarkable GPA of 9.52/10. Her academic endeavors also led her to Spain, where she earned an MSc in Neuroscience from Universidad Miguel Hernandez under the prestigious Severo Ochoa fellowship, graduating in the top 15% of her class. Her foundational education was a BSc in Biochemistry and Physiology at the University “Ss. Cyril and Methodius”, Macedonia, where she was recognized as the best student of her generation with a GPA of 9.74/10. Her diverse academic background across biochemistry, neuroscience, and molecular biology forms the basis of her integrative approach to biomedical research. 📖🧬🎓

🧪 Experience

Marija Gjorgoska currently holds dual roles at the University of Ljubljana’s Faculty of Medicine—as a Teaching Assistant and a Research Assistant. Since 2020, she has led critical efforts in LC-MS/MS method development and validation, genetic and proteomic cancer tissue analysis, and R-based bioinformatics. She actively supports literature review, manuscript preparation, and educational delivery. Her teaching spans courses such as Principles of Biochemistry and practical instruction for medical and PhD students in LC-MS/MS and steroid hormone biochemistry. Marija has also conducted laboratory teaching in General Biochemistry at her alma mater in Macedonia. Her professional development includes internships at the University of Birmingham’s Institute of Metabolism and the Macedonian Academy of Sciences and Arts, where she worked on rare diseases and HPV screening. Her hands-on expertise, leadership in research, and global training have made her an invaluable contributor to both education and science. 🔬📊👩‍🏫

🔬 Research Interests 

Marija’s research is rooted in translational biochemistry with a strong focus on hormonal signaling in cancer. She specializes in steroid hormones, particularly estrogen and androgens, and their role in gynecological malignancies such as ovarian and endometrial cancers. Her work employs advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS) to simultaneously profile endogenous steroid hormones. In addition, she explores the tumor microenvironment, cancer metabolism, and pre-receptor regulation mechanisms. Her recent studies delve into multi-steroid profiling combined with machine learning to identify novel biomarkers, demonstrating her innovative approach. She is also involved in Mendelian randomization to explore causal links between hormones and disease subtypes. Marija is deeply motivated to enhance the molecular understanding of hormone-related pathologies, aiming for clinical translation. Her interdisciplinary research bridges molecular biology, analytical chemistry, and bioinformatics, making significant contributions to cancer diagnostics and therapeutics. 🧬💉📈

🏆 Awards 

Marija Gjorgoska’s academic excellence and research innovation have been recognized through several prestigious awards. In 2023, she received the Practical Skills Grant from the Society of Endocrinology, UK, acknowledging her practical training in LC-MS/MS techniques. In 2021, her Master’s thesis on molecular biology earned her the Krka Recognition with Special Praise, awarded to outstanding postgraduate researchers in Slovenia. Her consistent top academic performance includes graduating among the top 15% in her neuroscience MSc program in Spain and being named the best student of the generation during her BSc studies in Macedonia. These honors reflect her exceptional academic record, technical expertise, and contributions to biomedical research. Her recognition at both national and international levels highlights her as a rising star in molecular medicine, particularly in cancer biochemistry and hormone signaling. 🏅🎖️📜

📚Top Noted  Publications 

1. Gjorgoska, M., & Lanišnik-Rižner, T. (2024)

Title: From fallopian tube epithelium to high-grade serous ovarian cancer
Journal: Progress in Lipid Research
Volume: 96
Article Number: 101302
DOI: 10.1016/j.plipres.2024.101302
Indexing: Cited in lipid metabolism and hormone-driven tumorigenesis literature.

2. Gjorgoska, M., & Lanišnik-Rižner, T. (2022)

Title: Integration of androgen hormones in endometrial cancer biology
Journal: Trends in Endocrinology and Metabolism
Volume: 33
Issue: 9
Pages: 639–651
DOI: 10.1016/j.tem.2022.06.005
Indexing: PubMed, Scopus, Web of Science

3. Lanišnik-Rižner, T., & Gjorgoska, M. (2024)

Title: Steroid sulfatase and sulfotransferases in gynecological cancers
Journal: Essays in Biochemistry
Article Code: EBC20230096
DOI: 10.1042/EBC20230096
Indexing: Biochemical Society journals, Web of Science

4. Gjorgoska, M., & Lanišnik-Rižner, T. (2021)

Title: Estrogens and the Schrödinger’s cat in ovarian tumors
Journal: Cancers
Volume: 13
Issue: 19
Article Number: 5011
DOI: 10.3390/cancers13195011
Indexing: PubMed Central, Scopus, DOAJ

5. Gjorgoska, M., Taylor, A.E., Smrkolj, Š., & Rižner, T.L. (2025)

Title: Multi-Steroid Profiling and Machine Learning in Endometrial Cancer
Journal: Cancers
Volume: 17
Article Number: 1679
DOI: 10.3390/cancers17061679
Indexing: Scopus, Web of Science, PubMed

6. Gjorgoska, M., & Lanišnik-Rižner, T. (2024)

Title: Simultaneous steroid hormone measurement via LC-MS/MS
Journal: Journal of Steroid Biochemistry and Molecular Biology
Volume: 243
Article Number: 106578
DOI: 10.1016/j.jsbmb.2024.106578
Indexing: PubMed, Scopus, Web of Science

7. Gjorgoska, M., Šturm, L., & Lanišnik-Rižner, T. (2024)

Title: Pre-receptor regulation of 11-oxyandrogens in endometrial cancer
Journal: Frontiers in Endocrinology
Volume: 15
DOI: 10.3389/fendo.2024.1282059
Indexing: PubMed Central, Web of Science

8. Marolt, N., Pavlič, R., Kreft, T., Gjorgoska, M., & Lanišnik-Rižner, T. (2024)

Title: Targeting estrogen metabolism in platinum-resistant ovarian cancer
Journal: Biomedicine & Pharmacotherapy
Volume: 177
Article Number: 117069
DOI: 10.1016/j.biopha.2024.117069
Indexing: Scopus, PubMed, Web of Science

9. Gjorgoska, M., & Lanišnik-Rižner, T. (In Press)

Title: Effect of androgens on endometriosis and ovarian neoplasms: A Mendelian randomization study
Journal: [Journal name not yet disclosed]
Status: In Press (2025 expected)
DOI: Pending
Indexing: Will be cited by GWAS-based hormonal disease studies.

Conclusion

Marija Gjorgoska exemplifies the qualities of a top-tier early-career researcher: intellectual rigor, consistent scholarly output, and growing leadership in cancer biochemistry. Her research contributions are both innovative and impactful, addressing real-world medical challenges with a solid methodological foundation.

Anam Ashraf | Structural Biology | Women Researcher Award

Dr. Anam Ashraf | Structural Biology | Women Researcher Award 

DHR Young Scientist, at Jamia Millia Islamia, India.

Dr. Anam Ashraf is a dynamic and accomplished researcher with a Ph.D. in Life Sciences, specializing in molecular and structural biology, drug discovery, and research communication. Her scholarly journey spans prestigious institutions like the National Institute of Immunology and Jamia Millia Islamia. With a flair for both benchwork and penwork, Dr. Ashraf excels in scientific writing, grant proposals, and research translation. She has significantly contributed to the understanding of pathogen biology, cancer therapeutics, and microbial resistance. Her collaborative projects and high-impact publications reflect her innovative mindset and interdisciplinary approach. As a co-corresponding author on multiple articles, she demonstrates leadership and scientific clarity. Dr. Ashraf continues to bridge the gap between complex molecular mechanisms and translational science, aspiring to channel her research acumen into impactful scientific writing and policy communication. She brings passion, precision, and purpose to every project she undertakes. 📚💡

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Anam Ashraf’s academic foundation is rooted in premier Indian institutions, beginning with a Bachelor’s in Biotechnology from Jamia Millia Islamia (2010–2013), where she cultivated her interest in molecular biology. She then pursued an M.Sc. in Biotechnology from South Asian University (2013–2015), engaging in research on microRNA-181a and its role in liver fibrosis. Her scholarly trajectory culminated in a Ph.D. from the National Institute of Immunology (2015–2021), focusing on the mechanistic properties of the enzyme HisI and histidine biosynthesis dynamics in Mycobacterium tuberculosis. During her doctoral research, Dr. Ashraf developed deep expertise in structural biology, molecular dynamics, and host-pathogen interactions. Her academic record is complemented by her qualification of the highly competitive DBT-JRF (Category I) national-level examination in 2015. Each stage of her education has honed her analytical thinking, experimental rigour, and communication skills, making her a standout scholar in the life sciences domain. 🎓🔬

🧪 Experience

Dr. Anam Ashraf’s professional journey reflects over a decade of laboratory and academic excellence. Currently serving as a DHR-Young Scientist at Jamia Millia Islamia (since September 2022), she previously held a Senior Research Fellowship (SRF) there from 2021 to 2022. Her experience encompasses structural analysis of enzymes, inhibitor screening, and molecular dynamics simulations. Dr. Ashraf’s diverse skill set includes scientific manuscript writing, bioinformatics, grant proposal development, and public speaking. She has played key roles in multiple interdisciplinary research teams, contributing as both experimentalist and co-corresponding author. Her collaborative work spans microbiology, oncology, and computational biology, positioning her at the forefront of translational biomedical research. Dr. Ashraf’s research outputs have been presented at leading global forums and published in prestigious journals. Her combination of scientific depth and communicative clarity makes her uniquely qualified for both research-intensive and science communication roles. 🧫🧠

🔍 Research Interests

Dr. Anam Ashraf’s research interests lie at the confluence of molecular biology, structural biology, and computational drug discovery. Her doctoral work on Mycobacterium tuberculosis explored enzyme dynamics in host infection contexts, laying a foundation for antimicrobial development. Passionate about solving real-world biomedical challenges, she actively explores oxidative stress pathways, transcriptional regulation in pathogens, and cancer therapeutics via natural compound screening. She is particularly interested in structure-guided drug design, using techniques like X-ray crystallography, molecular docking, and MD simulations. Her recent focus on targeting proteins like RfaH and Aurora Kinase B with plant-derived compounds reflects a translational vision for therapy. Additionally, Dr. Ashraf is intrigued by the gut-brain axis, microbial endocrinology, and the interface between microbiota and host metabolism. Her interdisciplinary expertise empowers her to dissect complex mechanisms and identify novel therapeutic targets. Her work exemplifies how basic science can fuel next-generation treatment strategies. 🔬💊🧠

🏆 Awards

Dr. Anam Ashraf has garnered numerous accolades throughout her academic and research career. She qualified for the prestigious DBT-JRF Category I examination in 2015, which supported her doctoral research at the National Institute of Immunology. Her oral and poster presentations have been recognized at both national and international platforms, including the AsCA 2024 Conference in Malaysia, Keystone Symposia in the USA, and INCD 2023 in Chandigarh, where her innovative work on antimicrobial and cancer therapeutics was spotlighted. Her selection as a DHR-Young Scientist further reflects the national recognition of her scientific contributions. Dr. Ashraf’s ability to distill complex research into accessible formats has also earned her commendation in interdisciplinary forums such as “Global Bio-India” and “Biophysika.” Her consistent presence at high-impact events demonstrates not only her scientific merit but also her commitment to disseminating knowledge across academia and industry. 🥇📢

📚Top Noted Publications

Dr. Anam Ashraf has published extensively in high-impact journals, with over 19 peer-reviewed articles, several as co-corresponding or equal author. Her publications span antimicrobial research, structural biology, oncology, and microbial endocrinology.

🔬 Structural Biology & Enzymology

  1. Crystal Structure of Thymidine Kinase

    • Authors: [Authors not specified]

    • Journal: BBA – Proteins and Proteomics

    • Year: 2025

    • Citations: 5+

    • DOI: [DOI not available]PubMed+6PubMed+6Frontiers+6PubMed+11PubMed+11Directory of Open Access Journals – DOAJ+11

  2. Structure-Guided Identification of MTH1 Inhibitors

    • Authors: [Authors not specified]

    • Journal: Chemical Papers

    • Year: 2025

    • Citations: 3

    • DOI: [DOI not available]

  3. PDB Structure Submission

    • PDB ID: 8Y7W

    • Year: 2024

    • Details: Structural data from a protein crystallography study

    • Link: RCSB PDB Entry

  4. Conformational Switch in PIM-1

    • Authors: [Authors not specified]

    • Journal: Computational Biology and Chemistry

    • Year: 2024

    • Citations: 2

    • DOI: [DOI not available]PubMed+6PubMed+6Frontiers+6Frontiers+10PubMed+10PubMed+10

  5. Effect of pH on TK Enzyme

    • Authors: [Authors not specified]

    • Journal: Journal of Biomolecular Structure and Dynamics

    • Year: 2023

    • DOI: [DOI not available]

🧬 Molecular Mechanisms & Disease Links

  1. Role of MTH1 in Oxidative Stress and Therapeutic Targeting of Cancer

    • Authors: [Authors not specified]

    • Journal: Redox Biology

    • Year: 2024

    • Citations: 4

    • DOI: 10.1016/j.redox.2024.103394ScienceDirect

  2. Microbial Endocrinology and Metabolism

    • Authors: [Authors not specified]

    • Journal: Molecular and Cellular Endocrinology

    • Year: 2024

    • Citations: 1

    • DOI: [DOI not available]PubMed+9PubMed+9ResearchGate+9Frontiers+4PubMed+4SpringerLink+4

  3. Targeting Transcriptional Regulatory Protein RfaH with Natural Compounds to Develop Novel Therapies Against Klebsiella pneumoniae

    • Authors: Anam Ashraf, Arunabh Choudhary, Mohammad Ali Khan, Saba Noor, Afzal Hussain, Mohamed F. Alajmi, Md Imtaiyaz Hassan

    • Journal: Journal of Biomolecular Structure and Dynamics

    • Year: 2024

    • DOI: 10.1080/07391102.2024.2427376Taylor & Francis Online+1ResearchGate+1

  4. Repurposing Rifaximin

    • Authors: [Authors not specified]

    • Year: 2024

    • Details: [Details not available]

🧪 Drug Discovery & Natural Compound Research

  1. Investigating the Chemo-Preventive Role of Noscapine in Lung Carcinoma via Therapeutic Targeting of Human Aurora Kinase B

    • Authors: [Authors not specified]

    • Journal: Molecular and Cellular Biochemistry

    • Year: 2024

    • Citations: 3

    • DOI: 10.1007/s11010-024-05036-7

  2. Probing Baicalin as Potential Inhibitor of Aurora Kinase B: A Step Towards Lung Cancer Therapy

    • Authors: Noor Saba, Arunabh Choudhury, Ali Raza, Anam Ashraf

    • Journal: International Journal of Biological Macromolecules

    • Year: 2024

    • DOI: 10.1016/j.ijbiomac.2023.128813

  3. Natural Compounds vs. Klebsiella

    • Authors: [Authors not specified]

    • Journal: Fitoterapia

    • Year: 2023

    • DOI: [DOI not available]

  4. CDK5 as Neuro Target

    • Authors: [Authors not specified]

    • Journal: International Journal of Biological Macromolecules

    • Year: 2023

    • DOI: [DOI not available]

  5. Triazole Inhibitor for Mycobacterium tuberculosis

    • Authors: [Authors not specified]

    • Journal: Proteins

    • Year: 2022

    • DOI: [DOI not available]

🧫 Tuberculosis & Metabolic Studies

  1. Histidine Biosynthesis in TB

    • Authors: [Authors not specified]

    • Journal: Communications Biology

    • Year: 2021

    • Citations: 10+

    • DOI: [DOI not available]

  2. Lipid Utilization in TB

    • Authors: [Authors not specified]

    • Journal: Journal of Biological Chemistry

    • Year: 2017

    • DOI: [DOI not available]

  3. Bacterioferritin Structure

    • Authors: [Authors not specified]

    • Journal: Acta Crystallographica Section F

    • Year: 2018

    • DOI: [DOI not available]

🫁 Disease-Focused Studies

  1. Molecular Blueprint of COPD

    • Authors: [Authors not specified]

    • Journal: Oxidative Medicine and Cellular Longevity

    • Year: 2023

    • Citations: 6

    • DOI: [DOI not available]

  2. Mineral Pitch and Cancer

    • Authors: [Authors not specified]

    • Journal: BMC Complementary and Alternative Medicine

    • Year: 2016

    • DOI: [DOI not available]

Conclusion

Dr. Anam Ashraf is highly suitable for the Research for Women Researcher Award, particularly based on:

  • Her consistent and impactful contributions to life sciences,

  • Strong publication and presentation record in relevant domains,

  • And her leadership in scientific writing, drug discovery, and structural biology.

With modest improvements in formal recognitions, mentorship visibility, and community science engagement, she could emerge as a leading candidate not only for this award but for broader international recognition.